Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NIPAL2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | CLECL1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | RAB11A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
mRNA | CD300C | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | RFESD | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | LCP2 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | UGT2B17 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
mRNA | CCL22 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | CD200R1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
mRNA | FAM78A | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |